 | • レポートコード：QYR9ST12390 • 出版社/出版日：QYResearch / 2019年9月10日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥518,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,036,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、ポリクローナル抗体の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、一次抗体、二次抗体に、用途別には、学術研究、商業にセグメント区分し、ポリクローナル抗体の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ポリクローナル抗体の世界市場概要 ・ポリクローナル抗体の製造コスト構成分析 ・ポリクローナル抗体の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ポリクローナル抗体の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ポリクローナル抗体のセグメント分析（種類別） （一次抗体、二次抗体） ・ポリクローナル抗体のセグメント分析（用途別） （学術研究、商業） ・ポリクローナル抗体の主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Merck、IGY Life Sciences、Abcam、Genway Biotech、Good Biotech、Gallus Immunotech、Creative Diagnostics、Agrisera、Innovagen AB、Capra Science、YO Proteins、GeneTex） ・ポリクローナル抗体の市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
Immunoglobulin Y (abbreviated as IgY) is a type of immunoglobulin which is the major antibody in bird, reptile, and lungfish blood. It is also found in high concentrations in chicken egg yolk. As with the other immunoglobulins, IgY is a class of proteins which are formed by the immune system in reaction to certain foreign substances, and specifically recognize them.IgY antibodies have a different structure from IgG, particularly in the Fc and hinge regions. The affinity maturation process of IgY is also different from IgG. These biological features underlie IgY’s competitive advantages over IgG. Shown in the four panels are several comparisons between IgY and IgG.
The global Polyclonal Antibodies market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Polyclonal Antibodies volume and value at global level, regional level and company level. From a global perspective, this report represents overall Polyclonal Antibodies market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Polyclonal Antibodies in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Polyclonal Antibodies manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Merck
IGY Life Sciences
Abcam
Genway Biotech
Good Biotech
Gallus Immunotech
Creative Diagnostics
Agrisera
Innovagen AB
Capra Science
YO Proteins
GeneTex
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Primary Antibody
Secondary Antibody
Segment by Application
Academic Research
Commercial
Table of Contents
Executive Summary
1 Industry Overview of Polyclonal Antibodies
1.1 Definition of Polyclonal Antibodies
1.2 Polyclonal Antibodies Segment by Type
1.2.1 Global Polyclonal Antibodies Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Primary Antibody
1.2.3 Secondary Antibody
1.3 Polyclonal Antibodies Segment by Applications
1.3.1 Global Polyclonal Antibodies Consumption Comparison by Applications (2014-2025)
1.3.2 Academic Research
1.3.3 Commercial
1.4 Global Polyclonal Antibodies Overall Market
1.4.1 Global Polyclonal Antibodies Revenue (2014-2025)
1.4.2 Global Polyclonal Antibodies Production (2014-2025)
1.4.3 North America Polyclonal Antibodies Status and Prospect (2014-2025)
1.4.4 Europe Polyclonal Antibodies Status and Prospect (2014-2025)
1.4.5 China Polyclonal Antibodies Status and Prospect (2014-2025)
1.4.6 Japan Polyclonal Antibodies Status and Prospect (2014-2025)
1.4.7 Southeast Asia Polyclonal Antibodies Status and Prospect (2014-2025)
1.4.8 India Polyclonal Antibodies Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Polyclonal Antibodies
2.3 Manufacturing Process Analysis of Polyclonal Antibodies
2.4 Industry Chain Structure of Polyclonal Antibodies
3 Development and Manufacturing Plants Analysis of Polyclonal Antibodies
3.1 Capacity and Commercial Production Date
3.2 Global Polyclonal Antibodies Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Polyclonal Antibodies
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Polyclonal Antibodies Production and Capacity Analysis
4.2 Polyclonal Antibodies Revenue Analysis
4.3 Polyclonal Antibodies Price Analysis
4.4 Market Concentration Degree
5 Polyclonal Antibodies Regional Market Analysis
5.1 Polyclonal Antibodies Production by Regions
5.1.1 Global Polyclonal Antibodies Production by Regions
5.1.2 Global Polyclonal Antibodies Revenue by Regions
5.2 Polyclonal Antibodies Consumption by Regions
5.3 North America Polyclonal Antibodies Market Analysis
5.3.1 North America Polyclonal Antibodies Production
5.3.2 North America Polyclonal Antibodies Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Polyclonal Antibodies Import and Export
5.4 Europe Polyclonal Antibodies Market Analysis
5.4.1 Europe Polyclonal Antibodies Production
5.4.2 Europe Polyclonal Antibodies Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Polyclonal Antibodies Import and Export
5.5 China Polyclonal Antibodies Market Analysis
5.5.1 China Polyclonal Antibodies Production
5.5.2 China Polyclonal Antibodies Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Polyclonal Antibodies Import and Export
5.6 Japan Polyclonal Antibodies Market Analysis
5.6.1 Japan Polyclonal Antibodies Production
5.6.2 Japan Polyclonal Antibodies Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Polyclonal Antibodies Import and Export
5.7 Southeast Asia Polyclonal Antibodies Market Analysis
5.7.1 Southeast Asia Polyclonal Antibodies Production
5.7.2 Southeast Asia Polyclonal Antibodies Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Polyclonal Antibodies Import and Export
5.8 India Polyclonal Antibodies Market Analysis
5.8.1 India Polyclonal Antibodies Production
5.8.2 India Polyclonal Antibodies Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Polyclonal Antibodies Import and Export
6 Polyclonal Antibodies Segment Market Analysis (by Type)
6.1 Global Polyclonal Antibodies Production by Type
6.2 Global Polyclonal Antibodies Revenue by Type
6.3 Polyclonal Antibodies Price by Type
7 Polyclonal Antibodies Segment Market Analysis (by Application)
7.1 Global Polyclonal Antibodies Consumption by Application
7.2 Global Polyclonal Antibodies Consumption Market Share by Application (2014-2019)
8 Polyclonal Antibodies Major Manufacturers Analysis
8.1 Merck
8.1.1 Merck Polyclonal Antibodies Production Sites and Area Served
8.1.2 Merck Product Introduction, Application and Specification
8.1.3 Merck Polyclonal Antibodies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 IGY Life Sciences
8.2.1 IGY Life Sciences Polyclonal Antibodies Production Sites and Area Served
8.2.2 IGY Life Sciences Product Introduction, Application and Specification
8.2.3 IGY Life Sciences Polyclonal Antibodies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Abcam
8.3.1 Abcam Polyclonal Antibodies Production Sites and Area Served
8.3.2 Abcam Product Introduction, Application and Specification
8.3.3 Abcam Polyclonal Antibodies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Genway Biotech
8.4.1 Genway Biotech Polyclonal Antibodies Production Sites and Area Served
8.4.2 Genway Biotech Product Introduction, Application and Specification
8.4.3 Genway Biotech Polyclonal Antibodies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Good Biotech
8.5.1 Good Biotech Polyclonal Antibodies Production Sites and Area Served
8.5.2 Good Biotech Product Introduction, Application and Specification
8.5.3 Good Biotech Polyclonal Antibodies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Gallus Immunotech
8.6.1 Gallus Immunotech Polyclonal Antibodies Production Sites and Area Served
8.6.2 Gallus Immunotech Product Introduction, Application and Specification
8.6.3 Gallus Immunotech Polyclonal Antibodies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Creative Diagnostics
8.7.1 Creative Diagnostics Polyclonal Antibodies Production Sites and Area Served
8.7.2 Creative Diagnostics Product Introduction, Application and Specification
8.7.3 Creative Diagnostics Polyclonal Antibodies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Agrisera
8.8.1 Agrisera Polyclonal Antibodies Production Sites and Area Served
8.8.2 Agrisera Product Introduction, Application and Specification
8.8.3 Agrisera Polyclonal Antibodies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Innovagen AB
8.9.1 Innovagen AB Polyclonal Antibodies Production Sites and Area Served
8.9.2 Innovagen AB Product Introduction, Application and Specification
8.9.3 Innovagen AB Polyclonal Antibodies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Capra Science
8.10.1 Capra Science Polyclonal Antibodies Production Sites and Area Served
8.10.2 Capra Science Product Introduction, Application and Specification
8.10.3 Capra Science Polyclonal Antibodies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 YO Proteins
8.12 GeneTex
9 Development Trend of Analysis of Polyclonal Antibodies Market
9.1 Global Polyclonal Antibodies Market Trend Analysis
9.1.1 Global Polyclonal Antibodies Market Size (Volume and Value) Forecast 2019-2025
9.2 Polyclonal Antibodies Regional Market Trend
9.2.1 North America Polyclonal Antibodies Forecast 2019-2025
9.2.2 Europe Polyclonal Antibodies Forecast 2019-2025
9.2.3 China Polyclonal Antibodies Forecast 2019-2025
9.2.4 Japan Polyclonal Antibodies Forecast 2019-2025
9.2.5 Southeast Asia Polyclonal Antibodies Forecast 2019-2025
9.2.6 India Polyclonal Antibodies Forecast 2019-2025
9.3 Polyclonal Antibodies Market Trend (Product Type)
9.4 Polyclonal Antibodies Market Trend (Application)
10 Marketing Channel, Distributors and Customers
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Polyclonal Antibodies Distributors List
10.3 Polyclonal Antibodies Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Polyclonal Antibodies
Table Global Polyclonal Antibodies Production (K Doses) Growth Rate Comparison by Types (2014-2025)
Figure Global Polyclonal Antibodies Production Market Share by Types in 2018
Figure Primary Antibody Product Picture
Figure Secondary Antibody Product Picture
Table Global Polyclonal Antibodies Consumption (K Doses) Comparison by Applications (2014-2025)
Figure Global Polyclonal Antibodies Consumption Market Share by Applications in 2018
Figure Academic Research
Figure Commercial
Figure Global Polyclonal Antibodies Revenue (Million USD) (2014-2025)
Figure Global Polyclonal Antibodies Production (K Doses) (2014-2025)
Figure North America Polyclonal Antibodies Market Size (Million USD) (2014-2025)
Figure Europe Polyclonal Antibodies Market Size (Million USD) (2014-2025)
Figure China Polyclonal Antibodies Market Size (Million USD) (2014-2025)
Figure Japan Polyclonal Antibodies Market Size (Million USD) (2014-2025)
Figure Southeast Asia Polyclonal Antibodies Market Size (Million USD) (2014-2025)
Figure India Polyclonal Antibodies Market Size (Million USD) (2014-2025)
Table Polyclonal Antibodies Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Polyclonal Antibodies in 2018
Figure Manufacturing Process Analysis of Polyclonal Antibodies
Figure Industry Chain Structure of Polyclonal Antibodies
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Polyclonal Antibodies Manufacturing Plants Distribution
Table Polyclonal Antibodies Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Polyclonal Antibodies Capacity (K Doses) of Major Manufacturers (2014-2019)
Table Polyclonal Antibodies Production (K Doses) of Major Manufacturers (2014-2019)
Table Polyclonal Antibodies Production Market Share of Major Manufacturers (2014-2019)
Figure Polyclonal Antibodies Production Share by Manufacturers in 2018
Table Polyclonal Antibodies Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Polyclonal Antibodies Revenue Market Share of Major Manufacturers (2014-2019)
Figure Polyclonal Antibodies Revenue Share by Manufacturers in 2018
Table Polyclonal Antibodies Average Price (USD/Dose) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Polyclonal Antibodies Production by Regions 2014-2019 (K Doses)
Table Global Polyclonal Antibodies Production Market Share by Regions 2014-2019
Figure Global Polyclonal Antibodies Production Market Share by Regions in 2018
Table Global Polyclonal Antibodies Revenue by Regions 2014-2019 (Million USD)
Table Global Polyclonal Antibodies Revenue Market Share by Regions 2014-2019
Figure Global Polyclonal Antibodies Revenue Market Share by Regions in 2018
Table Global Polyclonal Antibodies Consumption by Regions 2014-2019 (K Doses)
Table Global Polyclonal Antibodies Consumption Market Share by Regions 2014-2019
Figure North America Polyclonal Antibodies Production Growth Rate 2014-2019 (K Doses)
Figure North America Polyclonal Antibodies Revenue Growth Rate 2014-2019 (Million USD)
Table North America Polyclonal Antibodies Production, Consumption Import and Export (K Doses)
Figure Europe Polyclonal Antibodies Production Growth Rate 2014-2019 (K Doses)
Figure Europe Polyclonal Antibodies Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Polyclonal Antibodies Production, Consumption Import and Export (K Doses)
Figure China Polyclonal Antibodies Production Growth Rate 2014-2019 (K Doses)
Figure China Polyclonal Antibodies Revenue Growth Rate 2014-2019 (Million USD)
Table China Polyclonal Antibodies Production, Consumption Import and Export (K Doses)
Figure Japan Polyclonal Antibodies Production Growth Rate 2014-2019 (K Doses)
Figure Japan Polyclonal Antibodies Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Polyclonal Antibodies Production, Consumption Import and Export (K Doses)
Figure Southeast Asia Polyclonal Antibodies Production Growth Rate 2014-2019 (K Doses)
Figure Southeast Asia Polyclonal Antibodies Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Polyclonal Antibodies Production, Consumption Import and Export (K Doses)
Figure India Polyclonal Antibodies Production Growth Rate 2014-2019 (K Doses)
Figure India Polyclonal Antibodies Revenue Growth Rate 2014-2019 (Million USD)
Table India Polyclonal Antibodies Production, Consumption Import and Export (K Doses)
Figure Global Consumption Polyclonal Antibodies Market Share by Application (2014-2019)
Figure Global Value (Consumption) Polyclonal Antibodies Market Share by Application (2014-2019)
Table Merck Polyclonal Antibodies Production Sites and Area Served
Table Merck Polyclonal Antibodies Product Introduction, Application and Specification
Table Merck Polyclonal Antibodies Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Merck Polyclonal Antibodies Production Growth Rate (2014-2019)
Table Merck Polyclonal Antibodies Production Market Share (2014-2019)
Figure Merck Polyclonal Antibodies Revenue Market Share (2014-2019)
Table Merck Polyclonal Antibodies Main Business and Markets Served
Table IGY Life Sciences Polyclonal Antibodies Production Sites and Area Served
Table IGY Life Sciences Polyclonal Antibodies Product Introduction, Application and Specification
Table IGY Life Sciences Polyclonal Antibodies Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table IGY Life Sciences Polyclonal Antibodies Production Growth Rate (2014-2019)
Table IGY Life Sciences Polyclonal Antibodies Production Market Share (2014-2019)
Figure IGY Life Sciences Polyclonal Antibodies Revenue Market Share (2014-2019)
Table IGY Life Sciences Polyclonal Antibodies Main Business and Markets Served
Table Abcam Polyclonal Antibodies Production Sites and Area Served
Table Abcam Polyclonal Antibodies Product Introduction, Application and Specification
Table Abcam Polyclonal Antibodies Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Abcam Polyclonal Antibodies Production Growth Rate (2014-2019)
Table Abcam Polyclonal Antibodies Production Market Share (2014-2019)
Figure Abcam Polyclonal Antibodies Revenue Market Share (2014-2019)
Table Abcam Polyclonal Antibodies Main Business and Markets Served
Table Genway Biotech Polyclonal Antibodies Production Sites and Area Served
Table Genway Biotech Polyclonal Antibodies Product Introduction, Application and Specification
Table Genway Biotech Polyclonal Antibodies Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Genway Biotech Polyclonal Antibodies Production Growth Rate (2014-2019)
Table Genway Biotech Polyclonal Antibodies Production Market Share (2014-2019)
Figure Genway Biotech Polyclonal Antibodies Revenue Market Share (2014-2019)
Table Genway Biotech Polyclonal Antibodies Main Business and Markets Served
Table Good Biotech Polyclonal Antibodies Production Sites and Area Served
Table Good Biotech Polyclonal Antibodies Product Introduction, Application and Specification
Table Good Biotech Polyclonal Antibodies Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Good Biotech Polyclonal Antibodies Production Growth Rate (2014-2019)
Table Good Biotech Polyclonal Antibodies Production Market Share (2014-2019)
Figure Good Biotech Polyclonal Antibodies Revenue Market Share (2014-2019)
Table Good Biotech Polyclonal Antibodies Main Business and Markets Served
Table Gallus Immunotech Polyclonal Antibodies Production Sites and Area Served
Table Gallus Immunotech Polyclonal Antibodies Product Introduction, Application and Specification
Table Gallus Immunotech Polyclonal Antibodies Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Gallus Immunotech Polyclonal Antibodies Production Growth Rate (2014-2019)
Table Gallus Immunotech Polyclonal Antibodies Production Market Share (2014-2019)
Figure Gallus Immunotech Polyclonal Antibodies Revenue Market Share (2014-2019)
Table Gallus Immunotech Polyclonal Antibodies Main Business and Markets Served
Table Creative Diagnostics Polyclonal Antibodies Production Sites and Area Served
Table Creative Diagnostics Polyclonal Antibodies Product Introduction, Application and Specification
Table Creative Diagnostics Polyclonal Antibodies Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Creative Diagnostics Polyclonal Antibodies Production Growth Rate (2014-2019)
Table Creative Diagnostics Polyclonal Antibodies Production Market Share (2014-2019)
Figure Creative Diagnostics Polyclonal Antibodies Revenue Market Share (2014-2019)
Table Creative Diagnostics Polyclonal Antibodies Main Business and Markets Served
Table Agrisera Polyclonal Antibodies Production Sites and Area Served
Table Agrisera Polyclonal Antibodies Product Introduction, Application and Specification
Table Agrisera Polyclonal Antibodies Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Agrisera Polyclonal Antibodies Production Growth Rate (2014-2019)
Table Agrisera Polyclonal Antibodies Production Market Share (2014-2019)
Figure Agrisera Polyclonal Antibodies Revenue Market Share (2014-2019)
Table Agrisera Polyclonal Antibodies Main Business and Markets Served
Table Innovagen AB Polyclonal Antibodies Production Sites and Area Served
Table Innovagen AB Polyclonal Antibodies Product Introduction, Application and Specification
Table Innovagen AB Polyclonal Antibodies Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Innovagen AB Polyclonal Antibodies Production Growth Rate (2014-2019)
Table Innovagen AB Polyclonal Antibodies Production Market Share (2014-2019)
Figure Innovagen AB Polyclonal Antibodies Revenue Market Share (2014-2019)
Table Innovagen AB Polyclonal Antibodies Main Business and Markets Served
Table Capra Science Polyclonal Antibodies Production Sites and Area Served
Table Capra Science Polyclonal Antibodies Product Introduction, Application and Specification
Table Capra Science Polyclonal Antibodies Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Capra Science Polyclonal Antibodies Production Growth Rate (2014-2019)
Table Capra Science Polyclonal Antibodies Production Market Share (2014-2019)
Figure Capra Science Polyclonal Antibodies Revenue Market Share (2014-2019)
Table Capra Science Polyclonal Antibodies Main Business and Markets Served
Table YO Proteins Polyclonal Antibodies Production Sites and Area Served
Table GeneTex Polyclonal Antibodies Production Sites and Area Served
Figure Global Polyclonal Antibodies Production (K Doses) Growth Rate Forecast 2019-2025
Figure Global Polyclonal Antibodies Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Polyclonal Antibodies Sales Price (USD/Dose) Forecast 2019-2025
Figure North America Polyclonal Antibodies Production Growth Rate Forecast 2019-2025 (K Doses)
Figure North America Polyclonal Antibodies Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Polyclonal Antibodies Production Growth Rate Forecast 2019-2025 (K Doses)
Figure Europe Polyclonal Antibodies Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Polyclonal Antibodies Production Growth Rate Forecast 2019-2025 (K Doses)
Figure China Polyclonal Antibodies Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Polyclonal Antibodies Production Growth Rate Forecast 2019-2025 (K Doses)
Figure Japan Polyclonal Antibodies Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Polyclonal Antibodies Production Growth Rate Forecast 2019-2025 (K Doses)
Figure Southeast Asia Polyclonal Antibodies Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Polyclonal Antibodies Production Growth Rate Forecast 2019-2025 (K Doses)
Figure India Polyclonal Antibodies Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Doses) of Polyclonal Antibodies by Type (2019-2025)
Table Global Consumption (K Doses) of Polyclonal Antibodies by Application (2019-2025)
Table Polyclonal Antibodies Distributors List
Table Polyclonal Antibodies Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
ナノ抗体の世界市場：市場規模・現状・予測 Nanoantibodies or "nAb" are single-domain VHH antibodies derived from camelidae (camels, llamas, alpacas, etc.). Compared with conventional monoclonal and polyclonal antibodies, nAbs have the following advantages: Small size (~15kd) High affinity (frequently nanomolar range) High specificity Unsurpa…- HER2抗体の世界市場：市場規模・現状・予測 The demand of HER2 Antibodies is increasing, and primarily gaining from growing awareness regarding the prevalence of HER2 positive breast cancer. In 2018, the global HER2 Antibodies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% duri…
- 神経科抗体及びアッセイの世界市場：市場規模・現状・予測 The demand for Neuroscience Antibodies and Assays is increasing, due to the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries.In 2018, the global Neuroscience Antibodies and Assays market size was…
- がんモノクローナル抗体の世界市場：インサイト・予測 The mAbs, which are produced by genetic engineering, target antigens in cells, tissues, and organs. They are used in clinical applications to treat diseases with excellent efficacy and minimal side effects. Their MOA, absence of generic pathway, and therapeutic applications distinguish them from oth…
- 世界の小分子抗体市場：専門的調査 Antibodies against small molecules constitute an easy, fast and cost-efficient alternative to HPLC and mass spectrometry when it comes to small molecule detection. The global Small Molecule Antibodies market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growi…